beta
/European Medicines Regulatory Network (EMRN) workshop on Geographic Atrophy endpoints, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, 29 April 2026
NEWS

European Medicines Regulatory Network (EMRN) workshop on Geographic Atrophy endpoints, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, 29 April 2026

EMA
2026/04/07
European Medicines Regulatory Network (EMRN) workshop on Geographic Atrophy endpoints Event Human Add to calendar Google Calendar Apple Calendar Office365 Calendar Outlook Calendar Yahoo Calendar Date Wednesday, 29 April 2026, All day Location Online European Medicines Agency, Amsterdam, the Netherlands Live broadcast Event summary Geographic atrophy (GA) is a slowly progressing and seriously debilitating condition with a high prevalence and unmet medical need. GA has a major impact on patients/families from a health and quality of life perspective. To support a Centralised marketing authorisation for a medicinal product in GA, it is necessary to show a clinically relevant treatment benefit of the medicinal product on visual function. Alternative primary endpoints to demonstrate efficacy of the medicinal product, e.g based retinal imaging, must be able to robustly predict the clinically relevant treatment benefit of the medicinal product on visual function. Therefore, there is a need to discuss the state of the art on functional endpoints for GA and retinal imaging with stakeholders in order to facilitate medicinal product development for GA, and thus address the unmet need for many EU patients with GA. Relevant stakeholders include patients and carers, healthcare professionals, academics and industry concerned with the development of medicinal products for GA. The aims of the workshop are: to communicate the principles/regulatory expectations for endpoints to support the risk benefit assessment of medicinal products, to identify gaps in research and to encourage further necessary work on endpoints to meet regulatory expectations; to allow public presentation of: the state of the art on candidate functional endpoints in GA, and an overview of how structural changes and retinal function inter-relate; to encourage wider discussion from stakeholders into identified discussion points. Documents Agenda - European Medicines Regulatory Network workshop on Geographic Atrophy endpoints Draft Reference Number: Revision 1 English (EN) (451.36 KB - PDF) First published: 18/02/2026 Last updated: 07/04/2026 View Registration To register for the workshop, please follow this link: European Medicines Regulatory Network (EMRN) workshop on Geographic Atrophy endpoints Registration for online participation remains open until 14 April 2026. The event is live broadcast. Video recording is published after the event. Contact point GAworkshop@ema.europa.eu Related content European medicines regulatory network Share this page
Summary

European Medicines Regulatory Network (EMRN) workshop on Geographic Atrophy endpoints, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, 29 April 2026